From: High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
Case | Age | Sex | Intervals between CH attacks (months) | Methylprednisolone dose (intravenous) | Admission | Prednisolone dose and duration (daily oral) |
---|---|---|---|---|---|---|
1 | 54 | Male | Initial presentation | 250 mg (Days 1 and 2) | Yes | 10 mg, 90 days |
4 | 250 mg (Days 1–3) | Yes | none | |||
4 | 250 mg (Days 1 and 2) | Yes | 5 mg, 60 days | |||
5 | 250 mg (Day 1) | No | 5 mg, 180 days | |||
2 | 33 | Male | Initial presentation | 250 mg (Days 1–3, 7–9) | Yes | 20 mg, 10 days |
23 | 250 mg (Days 1 and 9) + 500 mg (Day 4) | No | 15 mg, 30 days | |||
11 | 500 mg (Days 1, 7, 11, and 13) | No | 10 mg, 40 days | |||
3 | 33 | Male | Initial presentation | 250 mg (Day 1) + 500 mg (Day 18) | No | none |
6 | 250 mg (Day 1) | No | none | |||
4 | 38 | Male | Initial presentation | 250 mg (Day 1) | No | none |
11 | 250 mg (Day 1) | No | none | |||
7 | 250 mg (Day 1) | No | none | |||
5 | 250 mg (Day 1) | No | none | |||
7 | 250 mg (Day 1) | No | none | |||
5 | 49 | Male | Initial presentation | 125 mg (Days 1 and 44) | No | none |
7 | 125 mg (Day 1) | No | none | |||
6 | 26 | Male | Initial presentation | 500 mg (Day 1) | No | none |
11 | 500 mg (Day 1) | No | none |